AbbVie is a leading global biopharmaceutical company specializing in the research, development, and commercialization of innovative medicines. With a strong focus on patient care, the company aims to address some of the world's most complex and serious diseases. AbbVie's extensive portfolio encompasses a wide range of therapeutic areas, including immunology, oncology, virology, and neuroscience. By leveraging its robust pipeline and collaborating with external partners, AbbVie seeks to deliver transformative treatments that improve the lives of millions of people worldwide. The company's commitment to advancing science and serving humanity is reflected in its continuous investments in research and development, strategic partnerships, and community outreach initiatives.
